At the time of writing, Centessa Pharmaceuticals plc ADR [CNTA] stock is trading at $13.75, down -0.29%. An important factor to consider is whether the stock is rising or falling in short-term value. The CNTA shares have gain 13.17% over the last week, with a monthly amount drifted -5.24%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] stock has seen the most recent analyst activity on March 31, 2025, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $38. On September 20, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $26 on the stock. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $33 on September 19, 2024. Oppenheimer initiated its recommendation with a Outperform and recommended $14 as its price target on July 18, 2024. Jefferies upgraded its rating to Buy for this stock on November 15, 2023, and upped its price target to $11. In a note dated October 26, 2023, Morgan Stanley upgraded an Equal-Weight rating on this stock and boosted its target price from $4 to $8.
For the past year, the stock price of Centessa Pharmaceuticals plc ADR fluctuated between $7.75 and $19.09. Currently, Wall Street analysts expect the stock to reach $27.5 within the next 12 months. Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] shares were valued at $13.75 at the most recent close of the market. An investor can expect a potential return of 100.0% based on the average CNTA price forecast.
Analyzing the CNTA fundamentals
According to Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA], the company’s sales were 0.00M for trailing twelve months, which represents an -100.00% plunge. To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.67 and Total Capital is -0.39. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.49 points at the first support level, and at 13.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.05, and for the 2nd resistance point, it is at 14.34.
Ratios To Look Out For
It is important to note that Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] has a current ratio of 9.25. On the other hand, the Quick Ratio is 9.25, and the Cash Ratio is 6.61.
Transactions by insiders
Recent insider trading involved HUSSAIN IQBAL J, Officer, that happened on Apr 28 ’25 when 2391.0 shares were purchased. Chief Business Officer, Weinhoff Gregory M completed a deal on Apr 25 ’25 to sell 11742.0 shares. Meanwhile, Officer HUSSAIN IQBAL J bought 3609.0 shares on Apr 25 ’25.
